Assessment of the Mitotic Spindle Assembly Checkpoint (SAC) as the Target of Anticancer Therapies

E-ISSN： 1873-5576|9|2|131-141

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.2, 2009-03, pp. : 131-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitotic Checkpoint: A Therapeutic Target in the Treatment of Human Cancer

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 97-104

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

By Matthews Thomas P Jones Alan M Collins Ian

Expert Opinion on Drug Discovery, Vol. 8, Iss. 6, 2013-10 ,pp. : 621-640

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the mitotic kinesin spindle protein

By Coleman Paul J Fraley Mark E

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1659-1667

Informa Healthcare

Access to resources Recommend Favorite

Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2816-2825

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Superoxide Dismutase: A Promising Target for New Anticancer Therapies

Current Medicinal Chemistry, Vol. 11, Iss. 10, 2004-05 ,pp. : 1299-1308

Bentham Science Publishers

Access to resources Recommend Favorite